{
  "Disease": [
    {"role": "user", "content": "Please identify the \"Disease\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Disease\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: The effects of two unselective potassium ( K ( + ) - ) channel blockers , quinine ( 12 . 5 , 25 and 50 mg / kg ) and 4 - aminopyridine ( 1 and 2 mg / kg ) , on conditioned place preference and biphasic changes in motor activity induced by morphine ( 10 mg / kg ) were tested in Wistar rats .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| conditioned place preference |\n| biphasic changes in motor activity |\n\nNote: I have identified the \"Disease\" entities as \"conditioned place preference\" and \"biphasic changes in motor activity\" as they are the conditions or states being affected by the administration of certain substances in the experiment."},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Disease\" and present the valid entities as a Markdown table with one column \"Disease\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| conditioned place preference |\n\nNote: I have reviewed the paragraph again and found that only the term \"conditioned place preference\" can be considered as a disease entity. The term \"biphasic changes in motor activity\" is a description of a physiological response rather than a disease."}
  ],
  "Chemical": [
    {"role": "user", "content": "Please identify the \"Chemical\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Chemical\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: The effects of two unselective potassium ( K ( + ) - ) channel blockers , quinine ( 12 . 5 , 25 and 50 mg / kg ) and 4 - aminopyridine ( 1 and 2 mg / kg ) , on conditioned place preference and biphasic changes in motor activity induced by morphine ( 10 mg / kg ) were tested in Wistar rats .\n\nLet's think step by step."},
    {"role": "assistant", "content": "Here are the chemical entities identified in the paragraph:\n\n| Chemical |\n| --- |\n| potassium ( K ( + ) - ) channel blockers |\n| quinine ( 12 . 5 , 25 and 50 mg / kg ) |\n| 4 - aminopyridine ( 1 and 2 mg / kg ) |\n| morphine ( 10 mg / kg ) |\n\nNote that the potassium ( K ( + ) - ) channel blockers are mentioned generally, while quinine, 4-aminopyridine, and morphine are all specified with dosages."},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Chemical\" and present the valid entities as a Markdown table with one column \"Chemical\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "After removing entities that do not clearly refer to \"Chemical\", we are left with the following:\n\n| Chemical |\n| --- |\n| quinine |\n| 4 - aminopyridine |\n| morphine |\n\nNote that the dosages have been removed as they are not considered part of the chemical names."}
  ]
}